• OPEN AN ACCOUNT
Indian Indices
Sensex
76,515.43 362.57
( 0.48%)
Global Indices
Nasdaq
53,423.66 -283.45
(-0.53%)
Dow Jones
7,737.34 -31.37
(-0.40%)
Hang Seng
65,002.68 788.20
(1.23%)
Nikkei 225
10,828.70 -2.82
(-0.03%)
Forex
USD-INR
94.48 -0.24
(-0.26%)
EUR-INR
109.71 0.00
(0.00%)
GBP-INR
127.63 -0.19
(-0.15%)
JPY-INR
0.60 0.01
(1.60%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
276.4035981
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
42.44
1048.83
EPS(TTM)
Face Value()
Div & Yield %
20.97
10
0.06
 

Steadfast Corporation reports consolidated net loss of Rs 0.01 crore in the March 2026 quarter
Jun 02,2026
Net loss of Steadfast Corporation reported to Rs 0.01 crore in the quarter ended March 2026 as against net profit of Rs 0.01 crore during the previous quarter ended March 2025. Sales rose 120.00% to Rs 0.88 crore in the quarter ended March 2026 as against Rs 0.40 crore during the previous quarter ended March 2025.

For the full year,no net profit/loss reported in the year ended March 2026 as against net profit of Rs 0.04 crore during the previous year ended March 2025. Sales rose 42.19% to Rs 0.91 crore in the year ended March 2026 as against Rs 0.64 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales0.880.40 120 0.910.64 42
OPM %-28.41-27.50 --85.71-73.44 -
PBDT-0.050.07 PL 0.020.14 -86
PBT-0.050.06 PL 0.020.09 -78
NP-0.010.01 PL 00.04 -100